|Opening date:||14 December 2020|
|Closing date for minimum data:
Application closing date and time:
|5pm ACT local time on 24 February 2021
5pm ACT local time on 10 March 2021
|Administering entity:||National Health and Medical Research Council|
|Total Amount Available (AUD):||$25,000,000.00|
|Estimated Grant Value (AUD):||Up to $4,000,000.00|
|Guidelines and Documents:||GO4535|
Objective: To support Australian medical research and medical innovation projects in one of the following streams:
- Stream 1: utilise existing evidence to develop or improve approaches for the early diagnosis of ovarian cancer, cancers of the pancreas, liver cancer or lung cancer that have a clinically feasible pathway to implementation
- Stream 2: enable approaches for the early diagnosis of cancers with unknown primary site that have a clinically feasible pathway to implementation.
Intended outcome: To improve the health and wellbeing of Australians by supporting research that improves the five-year relative survival rate for ovarian cancer, cancers of the pancreas, liver cancer, lung cancer and cancers with unknown primary site by enabling early diagnosis.
How to apply: NHMRC’s online granting system (Sapphire)